Literature DB >> 7478531

Regulation of c-Myb through protein phosphorylation and leucine zipper interactions.

R G Ramsay1, N Morrice, P Van Eeden, V Kanagasundaram, T Nomura, J De Blaquiere, S Ishii, R Wettenhall.   

Abstract

c-Myb function is modulated in part by a negative regulation domain which encompasses a leucine zipper (LZ). When E. coli-expressed c-Myb with wild type or mutated LZ proteins are assessed for DNA binding activity, the mutant form is substantially better at DNA binding than the wild type (WT) form. In contrast, the DNA binding activity of the WT protein is increased to an equivalent level of activity of the LZ-mutant when both are expressed in rabbit reticulocyte lysates (RRL) or insect cells. The possibility that phosphorylation overcomes the negative influence of the LZ was investigated. E. coli-expressed mutant, but not wild type c-Myb proteins, were shown to be substrates for Casein Kinase II (CKII) and cAMP-dependent Protein Kinase (PKA). The phosphorylation sites for CKII and PKA were serines 11 and 12, and 8 and 116, respectively. Serines 11 and 12 were found to be phosphorylated in recombinant wild type and mutant c-Myb expressed in insect cells and DNA binding was markedly reduced following phosphatase treatment. Substitution of serines 11 and 12 with glutamic acid and alanine in E. coli-expressed Myb demonstrated that these amino terminal residues influence the negative effect on DNA binding exerted by the LZ. Collectively, these observations support the notion that phosphorylation of serines 11 and 12 positively modulate DNA binding.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7478531

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  3 in total

1.  The highly conserved DNA-binding domains of A-, B- and c-Myb differ with respect to DNA-binding, phosphorylation and redox properties.

Authors:  S Bergholtz; T O Andersen ; K B Andersson; J Borrebaek; B Lüscher; O S Gabrielsen
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

2.  Minimal truncation of the c-myb gene product in rapid-onset B-cell lymphoma.

Authors:  W Jiang; M R Kanter; I Dunkel; R G Ramsay; K L Beemon; W S Hayward
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

Review 3.  Situational awareness: regulation of the myb transcription factor in differentiation, the cell cycle and oncogenesis.

Authors:  Olivia L George; Scott A Ness
Journal:  Cancers (Basel)       Date:  2014-10-02       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.